Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies.
Saved in:
| Title: | Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies. |
|---|---|
| Authors: | Janssen M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Leo A; Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg, Heidelberg, Germany., Wolf C; Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg, Heidelberg, Germany., Stenzinger M; Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg, Heidelberg, Germany., Bartenschlager M; Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital, Heidelberg, Germany., Brandt J; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Sauer S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Schmitt M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Dreger P; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Schlenk RF; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Denkinger CM; Division of Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany., Müller-Tidow C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany. |
| Source: | International journal of cancer [Int J Cancer] 2024 Aug 15; Vol. 155 (4), pp. 618-626. Date of Electronic Publication: 2024 May 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0215 |
|---|---|
| DOI: | 10.1002/ijc.34988 |
